These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19772944)

  • 21. Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.
    Wu Y; Bastian D; Schutt S; Nguyen H; Fu J; Heinrichs J; Xia C; Yu XZ
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1195-204. PubMed ID: 25846718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-22 promoted CD3+ T cell infiltration by IL-22R induced STAT3 phosphorylation in murine acute graft versus host disease target organs after allogeneic bone marrow transplantation.
    Zhao K; Ruan S; Tian Y; Zhao D; Chen C; Pan B; Yan Z; Yin L; Zhu S; Xu K
    Int Immunopharmacol; 2016 Oct; 39():383-388. PubMed ID: 27551984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
    Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
    Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal models of acute and chronic graft-versus-host disease.
    Hakim F; Fowler DH; Shearer GM; Gress RE
    Curr Protoc Immunol; 2001 May; Chapter 4():Unit 4.3. PubMed ID: 18432794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease.
    Tawara I; Maeda Y; Sun Y; Lowler KP; Liu C; Toubai T; McKenzie AN; Reddy P
    Exp Hematol; 2008 Aug; 36(8):988-96. PubMed ID: 18410989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic graft-versus-host-disease in CD34(+)-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease.
    Sonntag K; Eckert F; Welker C; Müller H; Müller F; Zips D; Sipos B; Klein R; Blank G; Feuchtinger T; Schumm M; Handgretinger R; Schilbach K
    J Autoimmun; 2015 Aug; 62():55-66. PubMed ID: 26143958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-6 blockade attenuates the development of murine sclerodermatous chronic graft-versus-host disease.
    Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
    J Invest Dermatol; 2012 Dec; 132(12):2752-61. PubMed ID: 22810302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.
    Du W; Leigh ND; Bian G; O'Neill RE; Mei L; Qiu J; Chen GL; Hahn T; Liu H; McCarthy PL; Cao X
    J Immunol; 2015 Nov; 195(9):4514-23. PubMed ID: 26392464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
    Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
    Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
    Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
    Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.
    Zeng D; Lewis D; Dejbakhsh-Jones S; Lan F; García-Ojeda M; Sibley R; Strober S
    J Exp Med; 1999 Apr; 189(7):1073-81. PubMed ID: 10190898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease.
    Via CS; Rus V; Gately MK; Finkelman FD
    J Immunol; 1994 Nov; 153(9):4040-7. PubMed ID: 7930611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired thymic negative selection causes autoimmune graft-versus-host disease.
    Teshima T; Reddy P; Liu C; Williams D; Cooke KR; Ferrara JL
    Blood; 2003 Jul; 102(2):429-35. PubMed ID: 12663438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of Th17/treg cell-associated cytokines in peripheral blood of patients with graft-versus-host disease and its clinical significance].
    Wang J; Wang XB; Wang J; Liu HL; Geng LQ; Ding KY; Sun ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):422-6. PubMed ID: 21518500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoids attenuate acute graft-versus-host disease by suppressing the cytotoxic capacity of CD8(+) T cells.
    Theiss-Suennemann J; Jörß K; Messmann JJ; Reichardt SD; Montes-Cobos E; Lühder F; Tuckermann JP; AWolff H; Dressel R; Gröne HJ; Strauß G; Reichardt HM
    J Pathol; 2015 Mar; 235(4):646-55. PubMed ID: 25358639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target antigens determine graft-versus-host disease phenotype.
    Kaplan DH; Anderson BE; McNiff JM; Jain D; Shlomchik MJ; Shlomchik WD
    J Immunol; 2004 Nov; 173(9):5467-75. PubMed ID: 15494494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.
    Yi T; Zhao D; Lin CL; Zhang C; Chen Y; Todorov I; LeBon T; Kandeel F; Forman S; Zeng D
    Blood; 2008 Sep; 112(5):2101-10. PubMed ID: 18596226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma.
    Hill GR; Olver SD; Kuns RD; Varelias A; Raffelt NC; Don AL; Markey KA; Wilson YA; Smyth MJ; Iwakura Y; Tocker J; Clouston AD; Macdonald KP
    Blood; 2010 Aug; 116(5):819-28. PubMed ID: 20435882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
    J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.
    Nagler A; Pines M; Abadi U; Pappo O; Zeira M; Rabbani E; Engelhardt D; Ohana M; Chowdhury NR; Chowdhury JR; Ilan Y
    Hepatology; 2000 Mar; 31(3):641-8. PubMed ID: 10706554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.